Rabies treatment demonstrated as safe and effective for use in children in first pediatric trial
Pre-COVID subway air polluted from DC to Boston, but New York region’s is the worst
10 February 2021Japan to start COVID vaccines despite syringe shortage
10 February 2021Rabies treatment demonstrated as safe and effective for use in children in first pediatric trial
A treatment, known as KEDRAB (Rabies Immune Globulin [Human]), currently used in the prevention of rabies has been demonstrated to be safe and effective for patients age 17 and under.
